|
subjectkey |
GUID |
|
Required |
The NDAR Global Unique Identifier (GUID) for research subject |
NDAR*
|
|
|
|
src_subject_id |
String |
20
|
Required |
Subject ID how it's defined in lab/project |
|
|
|
|
interview_date |
Date |
|
Required |
Date on which the interview/genetic test/sampling/imaging/biospecimen was completed. MM/DD/YYYY |
|
|
|
|
interview_age |
Integer |
|
Required |
Age in months at the time of the interview/test/sampling/imaging. |
0::1440
|
Age is rounded to chronological month. If the research participant is 15-days-old at time of interview, the appropriate value would be 0 months. If the participant is 16-days-old, the value would be 1 month.
|
|
|
sex |
String |
20
|
Required |
Sex of subject at birth |
M;F; O; NR
|
M = Male; F = Female; O=Other; NR = Not reported
|
gender |
|
cpsq01 |
Integer |
|
Recommended |
To what extent did you experience tingling DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq02 |
Integer |
|
Recommended |
To what extent did you experience an itching sensation DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq03 |
Integer |
|
Recommended |
To what extent did you experience a burning sensation DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq04 |
Integer |
|
Recommended |
To what extent did you experience pain DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq05 |
Integer |
|
Recommended |
To what extent did you experience fatigue DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq06 |
Integer |
|
Recommended |
To what extent did you experience nervousness DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq07 |
Integer |
|
Recommended |
To what extent did you experience headache DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq08 |
Integer |
|
Recommended |
To what extent did you experience difficulty concentrating DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq09 |
Integer |
|
Recommended |
To what extent did you experience a mood change DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq10 |
Integer |
|
Recommended |
To what extent did you experiencechange in your vision/visual perception DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq11 |
Integer |
|
Recommended |
To what extent did you experience visual sensation (seeing lights for example) associated with the start or end of stimulation/the stimulation DURING tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq12 |
Integer |
|
Recommended |
Other effects DURING tDAS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq13 |
String |
100
|
Recommended |
Describe other effects DURING tDAS/tACS |
|
|
|
|
cpsq14 |
Integer |
|
Recommended |
To what extent did you experience tingling AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq15 |
Integer |
|
Recommended |
To what extent did you experience an itching sensation AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq16 |
Integer |
|
Recommended |
To what extent did you experience a burning sensation AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq17 |
Integer |
|
Recommended |
To what extent did you experience pain AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq18 |
Integer |
|
Recommended |
To what extent did you experience fatigue AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq19 |
Integer |
|
Recommended |
To what extent did you experience nervousness AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq20 |
Integer |
|
Recommended |
To what extent did you experience headache AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq21 |
Integer |
|
Recommended |
To what extent did you experience difficulty concentrating AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq22 |
Integer |
|
Recommended |
To what extent did you experience a mood change AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq23 |
Integer |
|
Recommended |
To what extent did you experiencechange in your vision/visual perception AFTER tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq24 |
Integer |
|
Recommended |
Other effects AFTER tDAS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq25 |
String |
100
|
Recommended |
Describe other effects AFTER tDAS/tACS |
|
|
|
|
cpsq26 |
Integer |
|
Recommended |
To what extent did you experience tingling in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq27 |
Integer |
|
Recommended |
To what extent did you experience an itching sensation in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq28 |
Integer |
|
Recommended |
To what extent did you experience a burning sensation in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq29 |
Integer |
|
Recommended |
To what extent did you experience pain in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq30 |
Integer |
|
Recommended |
To what extent did you experience fatigue in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq31 |
Integer |
|
Recommended |
To what extent did you experience nervousness in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq32 |
Integer |
|
Recommended |
To what extent did you experience headache in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq33 |
Integer |
|
Recommended |
To what extent did you experience difficulty concentrating in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq34 |
Integer |
|
Recommended |
To what extent did you experience a mood change in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq35 |
Integer |
|
Recommended |
To what extent did you experiencechange in your vision/visual perception in the WEEK PRIOR to tDCS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq36 |
Integer |
|
Recommended |
To what extent did you experience visual sensation (seeing lights for example) associated with the start or end of stimulation/the stimulation in the WEEK PRIOR to tDCS/Tacs |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq37 |
Integer |
|
Recommended |
Other effects in the WEEK PRIOR to tDAS/tACS |
0::10
|
Higher number indicates greater symptom severity
|
|
|
cpsq38 |
String |
100
|
Recommended |
Describe other effects in the WEEK PRIOR to tDAS/tACS |
|
|
|